Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Omar Abdel-Rahman and Osama Ahmed |
January 2019 | Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease |
|
Liling Huang , Shiyu Jiang & Yuankai Shi |
February 2022 | Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data | futuremedicine |
|
Omar Abdel-Rahman |
March 2019 | Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials | Clinical Colorectal Cancer |
|
Wenjuan Mei, Anil Kapoor, Pierre Major, Bobby Shayegan, Damu Tang |
January 2017 | Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer | Journal of Xiangya Medicine |
|
Karyn Hede |
August 2017 | Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available | Journal of the National Cancer Institute |
|
Ganessan Kichenadasse MBBS, FRACP, John O. Miners PhD, Arduino A. Mangoni MBBS, PhD, FRACP, Christos S. Karapetis MBBS, FRACP, Ashley M. Hopkins PhD and Michael J. Sorich PhD |
May 2021 | Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy | Journal of the National Comprehensive Cancer Network |
|
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD |
January 2021 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |
|
Justyna Mierzynska, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Katarzyna Pogoda, Galina Velikova, Vesna Bjelic-Radisic, Fatima Cardoso, Etienne Brain, Michail Ignatiadis, Martine Piccart, Geertjan Van Tienhoven, Robert Mansel, Hans Wildiers, Andrew Bottomley, on behalf of EORTC and EORTC Breast Cancer Group |
December 2019 | Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer | European Journal of Cancer |
|
Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore |
July 2020 | Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) | National Academies Press |
|
Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller |
September 2020 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
|
Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller |
September 2020 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
|
Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates |
April 2019 | Resistance Models to EGFR Inhibition and Chemotherapy in Non-Small Cell Lung Cancer Via Analysis of Tumour Size Dynamics | Cancer Chemotherapy and Pharmacology |
|
Wei-xiang Qi, Shengguang Zhao, and Jiayi Chen |
October 2019 | Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment | Future Oncology |
|
Hirotaka Miyashita, Christina Cruz, Stephen Malamud |
May 2020 | Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate | Breast Cancer Research and Treatment |
